SB 616

Act No. 49
Public Acts of 2026
Approved by the Governor
July 21, 2026
Filed with the Secretary of State
July 23, 2026
EFFECTIVE
DATE: July 23, 2026
state of michigan
103rd Legislature
Regular session of 2026
Introduced by Senator Santana
ENROLLED SENATE BILL No. 616
AN ACT to amend 2022 PA 85,
entitled �An act to prohibit the commencement of civil actions relating to
opioids by certain governmental officers and entities,� by amending sections 2
and 3 (MCL 691.1672 and 691.1673), as amended by 2023 PA 228.
The People of the State of
Michigan enact:
Sec.
2. As used in this act:
(a) �Allergan settlement� means the master settlement
agreement arising out of the MDL and entered into by this state with Allergan
Pharmaceuticals.
(b) �Alvogen settlement� means the master settlement
agreement arising out of the MDL and entered into by this state with Alvogen,
Incorporated.
(c) �Amneal settlement� means the master settlement agreement
arising out of the MDL and entered into by this state with Amneal
Pharmaceuticals, LLC.
(d) �Apotex settlement� means the master settlement agreement
arising out of the MDL and entered into by this state with Apotex Corporation.
(e) �CVS settlement� means the master settlement agreement
arising out of the MDL and entered into by this state with CVS Pharmacy.
(f) �Distributor settlement� means the master settlement
agreement arising out of the MDL and entered into by this state with
AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation.
(g) �Hikma settlement� means the master settlement agreement
arising out of the MDL and entered into by this state with Hikma
Pharmaceuticals USA, Incorporated.
(h) �Indivior settlement� means the master settlement
agreement arising out of the MDL and entered into by this state with Indivior,
Incorporated.
(i) �Janssen settlement� means the master settlement
agreement arising out of the MDL and entered into by this state with Janssen
Pharmaceuticals, Inc.
(j) �Kroger settlement� means the master settlement agreement
arising out of the MDL and entered into by this state with the Kroger Co.
(k) �MDL� means In re Nat�l Prescription Opiate Litigation, multidistrict litigation consolidated in
the United States District Court for the Northern District of Ohio, Case
No. 1:17-MD-2804.
(l) �Mylan settlement� means the master
settlement agreement arising out of the MDL and entered into by this state with
Viatris, Inc.
(m) �Political subdivision� means a public body corporate in
this state, an agency of a public body corporate in this state, a
nonincorporated body in this state of whatever nature, or an agency of a
nonincorporated body in this state. Political subdivision includes a county,
city, village, township, school district, or special district or authority of
this state. Political subdivision does not include this state.
(n) �Purdue settlement� means the Governmental Entity and
Shareholder Direct Settlement Agreement in the bankruptcy action In re
Purdue Pharma LP et al, Case No. 19-23649 (SHL) (Bankr SDNY), to which this
state is a party.
(o) �Sun settlement� means the master settlement agreement
arising out of the MDL and entered into by this state with Sun Pharmaceuticals,
Incorporated.
(p) �Teva settlement� means the master settlement agreement
arising out of the MDL and entered into by this state with Teva
Pharmaceuticals.
(q) �Walgreens national settlement� means the master
settlement agreement arising out of the MDL and entered into by this state with
Walgreens Pharmacy.
(r) �Walmart settlement� means the master settlement
agreement arising out of the MDL and entered into by this state with Walmart.
(s) �Zydus settlement� means the master settlement agreement
arising out of the MDL and entered into by this state with Zydus
Pharmaceuticals (USA), Inc.
Sec.
3. A political subdivision of this state shall not commence or maintain an
action as follows:
(a) After January 1, 2021, an action related to the released
claims as defined in the distributor settlement against the released entities
as defined in the distributor settlement.
(b) After January 1, 2021, an action related to the released
claims as defined in the Janssen settlement against the released entities as
defined in the Janssen settlement.
(c) After January 1, 2022, an action related to the released
claims as defined in the Allergan settlement against the released entities as
defined in the Allergan settlement.
(d) After January 1, 2022, an action related to the released
claims as defined in the CVS settlement against the released entities as
defined in the CVS settlement.
(e) After January 1, 2022, an action related to the released
claims as defined in the Teva settlement against the released entities as
defined in the Teva settlement.
(f) After January 1, 2022, an action related to the released
claims as defined in the Walgreens national settlement against the released
entities as defined in the Walgreens national settlement.
(g) After January 1, 2022, an action related to the released
claims as defined in the Walmart settlement against the released entities as
defined in the Walmart settlement.
(h) After January 1, 2024, an action related to the released
claims as defined in the Kroger settlement against the released entities as
defined in the Kroger settlement.
(i) After January 1, 2025, an action related to the
Shareholder Released Claims as defined in the Purdue settlement against the
Shareholder Released Persons as defined in the Purdue settlement.
(j) After January 1, 2025, an action related to the released
claims as defined in the Alvogen settlement against the released entities as
defined in the Alvogen settlement.
(k) After January 1, 2025, an action related to the released
claims as defined in the Amneal settlement against the released entities as
defined in the Amneal settlement.
(l) After January 1, 2025, an action related
to the released claims as defined in the Apotex settlement against the released
entities as defined in the Apotex settlement.
(m) After January 1, 2025, an action related to the released
claims as defined in the Hikma settlement against the released entities as
defined in the Hikma settlement.
(n) After January 1, 2025, an action related to the released
claims as defined in the Indivior settlement against the released entities as
defined in the Indivior settlement.
(o) After January 1, 2025, an action related to the released
claims as defined in the Mylan settlement against the released entities as
defined in the Mylan settlement.
(p) After January 1, 2025, an action related to the released
claims as defined in the Sun settlement against the released entities as
defined in the Sun settlement.
(q) After January 1, 2025, an action related to the released
claims as defined in the Zydus settlement against the released entities as
defined in the Zydus settlement.
This act is ordered to take
immediate effect.
Secretary of the Senate
Clerk of the House of
Representatives
Approved___________________________________________
____________________________________________________
Governor